Advertisement
Screener

Clovis Oncology, Inc. Interest Expense, Debt, Excluding Amortization

Clovis Oncology, Inc. Interest Expense, Debt, Excluding Amortization

Clovis Oncology, Inc. reported Interest Expense, Debt, Excluding Amortization of $2.55 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2022-11-09

  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for the quarter ending 2022-09-30 was $2.55M, a 11.65% decline year-over-year.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for the quarter ending 2022-06-30 was $2.55M, a 13.65% decline year-over-year.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for the quarter ending 2022-03-31 was $2.55M, a 14.38% decline year-over-year.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for the quarter ending 2021-12-31 was $2.55M, a 12.59% decline year-over-year.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for fiscal 2021 was $11.36M, a 4.78% decline from fiscal 2020.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for fiscal 2020 was $11.93M, a 12.76% decline from fiscal 2019.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for fiscal 2019 was $13.68M, a 39.42% increase from fiscal 2018.
  • Clovis Oncology, Inc. interest expense, debt, excluding amortization for fiscal 2018 was $9.81M, a 36.51% increase from fiscal 2017.
Period endInterest Expense, Debt, Excluding Amortization 3 monthInterest Expense, Debt, Excluding Amortization 6 monthInterest Expense, Debt, Excluding Amortization 9 monthInterest Expense, Debt, Excluding Amortization 12 month
2022-09-30$2.55M
10-Q · filed 2022-11-09
$5.10M
derived: sum of 2 quarters · filed 2022-11-09
$7.65M
10-Q · filed 2022-11-09
$10.20M
derived: sum of 4 quarters · filed 2022-11-09
2022-06-30$2.55M
10-Q · filed 2022-08-08
$5.10M
10-Q · filed 2022-08-08
$7.65M
derived: sum of 3 quarters · filed 2022-08-08
$10.53M
derived: sum of 4 quarters · filed 2022-11-09
2022-03-31$2.55M
10-Q · filed 2022-05-05
$5.10M
derived: sum of 2 quarters · filed 2022-05-05
$7.98M
derived: sum of 3 quarters · filed 2022-11-09
$10.94M
derived: sum of 4 quarters · filed 2022-11-09
2021-12-31$2.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$5.43M
derived: sum of 2 quarters · filed 2022-11-09
$8.39M
derived: sum of 3 quarters · filed 2022-11-09
$11.36M
10-K · filed 2022-02-24
2021-09-30$2.88M
10-Q · filed 2022-11-09
$5.84M
derived: sum of 2 quarters · filed 2022-11-09
$8.81M
10-Q · filed 2022-11-09
$11.73M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$2.95M
10-Q · filed 2022-08-08
$5.93M
10-Q · filed 2022-08-08
$8.85M
derived: sum of 3 quarters · filed 2022-08-08
$11.87M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$2.98M
10-Q · filed 2022-05-05
$5.89M
derived: sum of 2 quarters · filed 2022-05-05
$8.92M
derived: sum of 3 quarters · filed 2022-05-05
$11.73M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$2.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$5.94M
derived: sum of 2 quarters · filed 2022-02-24
$8.75M
derived: sum of 3 quarters · filed 2022-02-24
$11.93M
10-K · filed 2022-02-24
2020-09-30$3.02M
10-Q · filed 2021-11-03
$5.83M
derived: sum of 2 quarters · filed 2021-11-03
$9.02M
10-Q · filed 2021-11-03
$13.52M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$2.81M
10-Q · filed 2021-08-04
$5.99M
10-Q · filed 2021-08-04
$10.50M
derived: sum of 3 quarters · filed 2022-02-24
$14.21M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$3.18M
10-Q · filed 2021-05-05
$7.69M
derived: sum of 2 quarters · filed 2022-02-24
$11.39M
derived: sum of 3 quarters · filed 2022-02-24
$14.13M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$8.21M
derived: sum of 2 quarters · filed 2022-02-24
$10.95M
derived: sum of 3 quarters · filed 2022-02-24
$13.68M
10-K · filed 2022-02-24
2019-09-30$3.71M
10-Q · filed 2020-11-05
$6.44M
derived: sum of 2 quarters · filed 2020-11-05
$9.18M
10-Q · filed 2020-11-05
$11.91M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$2.73M
10-Q · filed 2020-08-07
$5.47M
10-Q · filed 2020-08-07
$8.20M
derived: sum of 3 quarters · filed 2021-02-25
$10.94M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$2.73M
10-Q · filed 2020-05-06
$5.47M
derived: sum of 2 quarters · filed 2021-02-25
$8.20M
derived: sum of 3 quarters · filed 2021-02-25
$10.75M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$5.47M
derived: sum of 2 quarters · filed 2021-02-25
$8.02M
derived: sum of 3 quarters · filed 2021-02-25
$9.81M
10-K · filed 2021-02-25
2018-09-30$2.73M
10-Q · filed 2019-11-07
$5.28M
derived: sum of 2 quarters · filed 2019-11-07
$7.08M
10-Q · filed 2019-11-07
$8.88M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$2.55M
10-Q · filed 2019-08-02
$4.34M
10-Q · filed 2019-08-02
$6.14M
derived: sum of 3 quarters · filed 2020-02-26
$7.94M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.80M
10-Q · filed 2019-05-07
$3.59M
derived: sum of 2 quarters · filed 2020-02-26
$5.39M
derived: sum of 3 quarters · filed 2020-02-26
$7.19M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$3.59M
derived: sum of 2 quarters · filed 2020-02-26
$5.39M
derived: sum of 3 quarters · filed 2020-02-26
$7.19M
10-K · filed 2020-02-26
2017-09-30$1.80M
10-Q · filed 2018-11-01
$3.59M
derived: sum of 2 quarters · filed 2018-11-01
$5.39M
10-Q · filed 2018-11-01
$7.19M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$1.80M
10-Q · filed 2018-08-02
$3.59M
10-Q · filed 2018-08-02
$5.39M
derived: sum of 3 quarters · filed 2019-02-28
$7.19M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$1.80M
10-Q · filed 2018-05-09
$3.59M
derived: sum of 2 quarters · filed 2019-02-28
$5.39M
derived: sum of 3 quarters · filed 2019-02-28
$7.19M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$3.59M
derived: sum of 2 quarters · filed 2019-02-28
$5.39M
derived: sum of 3 quarters · filed 2019-02-28
$7.19M
10-K · filed 2019-02-28
2016-09-30$1.80M
10-Q · filed 2017-11-02
$3.59M
derived: sum of 2 quarters · filed 2017-11-02
$5.39M
10-Q · filed 2017-11-02
$7.19M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$1.80M
10-Q · filed 2017-08-03
$3.59M
10-Q · filed 2017-08-03
$5.39M
derived: sum of 3 quarters · filed 2018-02-27
$7.19M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$1.80M
10-Q · filed 2017-05-04
$3.59M
derived: sum of 2 quarters · filed 2018-02-27
$5.39M
derived: sum of 3 quarters · filed 2018-02-27
$7.19M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$3.59M
derived: sum of 2 quarters · filed 2018-02-27
$5.39M
derived: sum of 3 quarters · filed 2018-02-27
$7.17M
10-K · filed 2018-02-27
2015-09-30$1.80M
10-Q · filed 2016-11-04
$3.59M
derived: sum of 2 quarters · filed 2016-11-04
$5.37M
10-Q · filed 2016-11-04
$7.17M
derived: sum of 4 quarters · filed 2016-11-04
2015-06-30$1.80M
10-Q · filed 2016-08-09
$3.57M
10-Q · filed 2016-08-09
$5.37M
derived: sum of 3 quarters · filed 2016-08-09
$5.81M
derived: sum of 4 quarters · filed 2016-08-09
2015-03-31$1.78M
10-Q · filed 2016-05-09
$3.57M
derived: sum of 2 quarters · filed 2016-05-09
$4.01M
derived: sum of 3 quarters · filed 2016-05-09
2014-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$2.24M
derived: sum of 2 quarters · filed 2016-02-29
$2.24M
10-K · filed 2016-02-29
2014-09-30$439.00K
10-Q · filed 2015-11-06
$439.00K
10-Q · filed 2015-11-06